Cosmos Health Inc (COSM)

$0.80 -0.25 (-24.05%)
Market Cap 22.93M
Revenue (ttm) 54.43M
Net Income (ttm) -16.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.73%
Debt to Equity Ratio 0.36
Volume 1,561,900
Avg Vol 658,508
Day's Range N/A - N/A
Shares Out 28.75M
Stochastic %K 17%
Beta 5.33
Analysts Strong Buy
Price Target $3.00

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
141 West Jackson Boulevard, Suite 4236, Chicago, United States
Luvmepup
Luvmepup Aug. 11 at 12:38 AM
$COSM I warned you about the paid Pumpers!
0 · Reply
Luvmepup
Luvmepup Aug. 10 at 9:46 PM
$COSM Baggies, it must be a terrible feeling knowing you're about to lose more money in less than 12 hours.
0 · Reply
Userabg
Userabg Aug. 10 at 4:43 PM
$COSM Looks like a quick trade coming up tomorrow - in and out and adios.
0 · Reply
Luvmepup
Luvmepup Aug. 9 at 9:57 PM
$COSM Folks, just a little reminder for the new baggies. The 2 days this was over $1 meant nothing. In order for this scam to regain compliance with Nasdaq by Nov 3rd or be delisted, they have to stay at/above $1 for 10 STRAIGHT business days. There's nothing they are working on this year that will KEEP this over $1 for 10 straight days ... and please don't even think about earnings ... net profits will be a complete disaster as usual.
1 · Reply
Kid_Shelleen
Kid_Shelleen Aug. 9 at 9:50 PM
$COSM alert! Eth up 5%
1 · Reply
Sachi_Da
Sachi_Da Aug. 9 at 8:52 PM
$AMC $COSM $GME $IXHL $RR
0 · Reply
Ak2717
Ak2717 Aug. 9 at 8:37 PM
$IXHL if you know what’s going on with this stock, analyze the below points to clear your doubts and understand what you are holding.. 🔥 From “Dead” to 🚀 – The Dark Pool Trap Before Epic Short Squeezes 🔥 Classic Dark Pool → Short Squeeze Plays 1. $GME (2021): Heavy dark pool routing hid buys → retail squeeze +1,500%. 2. $AMC (2021): Weeks of suppression → breakout after shorts trapped +800%. 3. $BBBY (2022): Hidden selling in dark pools → sudden spike when shorts covered. 4. $COSM (2022): Algo suppression broke → 10x move in days. 5. $RR (2024): Dark pool selling for weeks → squeeze from $0.34 → $5.20. 6. $IXHL (2025?): Current heavy dark pool activity & algo suppression… pattern looks familiar 👀 💡 Pattern: Suppression delays the move, but once shorts lose control, the rally is violent. WE ARE HOLDING THE GOLD 💪💪
2 · Reply
William_H_Bonney
William_H_Bonney Aug. 9 at 6:07 PM
$COSM Our bear here forget that they pump this most likely to regain compliance, just like a year ago. After that it’s possible it will go back down again. But as for now we haven’t reach compliance yet. So the question for the bears is why COSM should be satisfied to reach dollar level only for two days when they need 10 trading days for compliance? Maybe our bears will learn the hard way..
0 · Reply
SEC_LIARS
SEC_LIARS Aug. 9 at 5:29 PM
$COSM I know this scam well because they’ve been pulling the same trick for years. That’s why last time I shorted at $1 and covered at $0.30, and this time I shorted at $1.20 — and sure enough, my prediction was right again.
0 · Reply
William_H_Bonney
William_H_Bonney Aug. 9 at 10:50 AM
$COSM We had 11M volume the day we went from $0,76 to $1,15. Yesterday 1,4M in volume brought us all the way back to $0,76 from over the dollar. Weird how it works.
3 · Reply
Latest News on COSM
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Aug 6, 2025, 9:20 AM EDT - 4 days ago

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Jun 24, 2025, 10:55 AM EDT - 6 weeks ago

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 2:30 PM EDT - 3 months ago

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 9:30 AM EDT - 3 months ago

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

May 7, 2025, 2:30 PM EDT - 3 months ago

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

May 6, 2025, 1:40 PM EDT - 3 months ago

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Apr 30, 2025, 12:50 PM EDT - 3 months ago

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Apr 16, 2025, 12:45 PM EDT - 4 months ago

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Apr 9, 2025, 1:40 PM EDT - 4 months ago

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Apr 8, 2025, 10:45 AM EDT - 4 months ago

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Feb 26, 2025, 11:30 AM EST - 5 months ago

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Feb 18, 2025, 8:30 AM EST - 6 months ago

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Feb 11, 2025, 10:15 AM EST - 6 months ago

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Feb 10, 2025, 1:30 PM EST - 6 months ago

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Feb 10, 2025, 9:45 AM EST - 6 months ago

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Feb 7, 2025, 10:00 AM EST - 6 months ago

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Feb 6, 2025, 3:50 PM EST - 6 months ago

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Feb 5, 2025, 11:05 AM EST - 6 months ago

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Jan 28, 2025, 11:00 AM EST - 6 months ago

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Jan 27, 2025, 3:50 PM EST - 6 months ago

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 7 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

VRAX

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Jan 22, 2025, 8:00 AM EST - 7 months ago

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Jan 21, 2025, 3:00 PM EST - 7 months ago

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 7 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

VRAX

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Dec 26, 2024, 1:30 PM EST - 8 months ago

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Dec 23, 2024, 9:25 AM EST - 8 months ago

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Nov 18, 2024, 8:00 AM EST - 9 months ago

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Nov 15, 2024, 10:20 AM EST - 9 months ago

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Cosmos Health Issues Letter to Shareholders

Nov 12, 2024, 12:00 PM EST - 9 months ago

Cosmos Health Issues Letter to Shareholders

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Nov 1, 2024, 12:30 PM EDT - 10 months ago

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Sep 25, 2024, 9:25 AM EDT - 11 months ago

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Sep 23, 2024, 12:55 PM EDT - 11 months ago

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Sep 23, 2024, 9:00 AM EDT - 11 months ago

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Sep 19, 2024, 3:40 PM EDT - 11 months ago

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Sep 18, 2024, 1:30 PM EDT - 11 months ago

Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 11 months ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

VRAX

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 11 months ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

VRAX

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Aug 23, 2024, 9:35 AM EDT - 1 year ago

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

VRAX

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs.

Aug 20, 2024, 12:20 PM EDT - 1 year ago

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs.

Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit

Aug 20, 2024, 9:00 AM EDT - 1 year ago

Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

Aug 8, 2024, 1:00 PM EDT - 1 year ago

Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

Aug 6, 2024, 9:00 AM EDT - 1 year ago

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

Jul 25, 2024, 2:45 PM EDT - 1 year ago

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

Jul 25, 2024, 11:40 AM EDT - 1 year ago

Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity

Jul 24, 2024, 10:55 AM EDT - 1 year ago

Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity

Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

Jul 18, 2024, 3:45 PM EDT - 1 year ago

Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market

Jul 10, 2024, 3:45 PM EDT - 1 year ago

Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market

Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually

Jul 9, 2024, 2:00 PM EDT - 1 year ago

Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually

Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

Jul 1, 2024, 11:20 AM EDT - 1 year ago

Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

Luvmepup
Luvmepup Aug. 11 at 12:38 AM
$COSM I warned you about the paid Pumpers!
0 · Reply
Luvmepup
Luvmepup Aug. 10 at 9:46 PM
$COSM Baggies, it must be a terrible feeling knowing you're about to lose more money in less than 12 hours.
0 · Reply
Userabg
Userabg Aug. 10 at 4:43 PM
$COSM Looks like a quick trade coming up tomorrow - in and out and adios.
0 · Reply
Luvmepup
Luvmepup Aug. 9 at 9:57 PM
$COSM Folks, just a little reminder for the new baggies. The 2 days this was over $1 meant nothing. In order for this scam to regain compliance with Nasdaq by Nov 3rd or be delisted, they have to stay at/above $1 for 10 STRAIGHT business days. There's nothing they are working on this year that will KEEP this over $1 for 10 straight days ... and please don't even think about earnings ... net profits will be a complete disaster as usual.
1 · Reply
Kid_Shelleen
Kid_Shelleen Aug. 9 at 9:50 PM
$COSM alert! Eth up 5%
1 · Reply
Sachi_Da
Sachi_Da Aug. 9 at 8:52 PM
$AMC $COSM $GME $IXHL $RR
0 · Reply
Ak2717
Ak2717 Aug. 9 at 8:37 PM
$IXHL if you know what’s going on with this stock, analyze the below points to clear your doubts and understand what you are holding.. 🔥 From “Dead” to 🚀 – The Dark Pool Trap Before Epic Short Squeezes 🔥 Classic Dark Pool → Short Squeeze Plays 1. $GME (2021): Heavy dark pool routing hid buys → retail squeeze +1,500%. 2. $AMC (2021): Weeks of suppression → breakout after shorts trapped +800%. 3. $BBBY (2022): Hidden selling in dark pools → sudden spike when shorts covered. 4. $COSM (2022): Algo suppression broke → 10x move in days. 5. $RR (2024): Dark pool selling for weeks → squeeze from $0.34 → $5.20. 6. $IXHL (2025?): Current heavy dark pool activity & algo suppression… pattern looks familiar 👀 💡 Pattern: Suppression delays the move, but once shorts lose control, the rally is violent. WE ARE HOLDING THE GOLD 💪💪
2 · Reply
William_H_Bonney
William_H_Bonney Aug. 9 at 6:07 PM
$COSM Our bear here forget that they pump this most likely to regain compliance, just like a year ago. After that it’s possible it will go back down again. But as for now we haven’t reach compliance yet. So the question for the bears is why COSM should be satisfied to reach dollar level only for two days when they need 10 trading days for compliance? Maybe our bears will learn the hard way..
0 · Reply
SEC_LIARS
SEC_LIARS Aug. 9 at 5:29 PM
$COSM I know this scam well because they’ve been pulling the same trick for years. That’s why last time I shorted at $1 and covered at $0.30, and this time I shorted at $1.20 — and sure enough, my prediction was right again.
0 · Reply
William_H_Bonney
William_H_Bonney Aug. 9 at 10:50 AM
$COSM We had 11M volume the day we went from $0,76 to $1,15. Yesterday 1,4M in volume brought us all the way back to $0,76 from over the dollar. Weird how it works.
3 · Reply
Kid_Shelleen
Kid_Shelleen Aug. 9 at 2:55 AM
$COSM Go "listen to the music"- Doobies
0 · Reply
Kid_Shelleen
Kid_Shelleen Aug. 9 at 2:51 AM
$COSM Have a fun weekend, and a better week.
0 · Reply
Joby099
Joby099 Aug. 9 at 2:14 AM
$COSM
1 · Reply
SlaveKing
SlaveKing Aug. 9 at 1:50 AM
$COSM No one should be surprised that it has come down. It just needs to cool off a bit. Still in bull hands but that could change easily with low volume. Greg has his work cut out for him if he's to regain retail confidence. They would need to have a breakthrough in one of their trials to really get many on board and... stop screwing over the stock price with reverse splits. Allow your company to profit. Hell... maybe the board should take a page from $GME and not take a salary. Show your investors that you truly believe in your company.
1 · Reply
Luvmepup
Luvmepup Aug. 8 at 11:55 PM
$COSM I take that back ... $0.60's instead. You baggies are getting slaughtered both during reg hours and now AH. Hey crooked CEO, announce the Reverse Split already ... we all know it's inevitable!
0 · Reply
Kid_Shelleen
Kid_Shelleen Aug. 8 at 11:18 PM
$COSM Swing batta, batta. Till you get HR!
0 · Reply
JoseGilberto109
JoseGilberto109 Aug. 8 at 11:14 PM
Wow what is happening to SNSE right now!? Seems like ALL volume and momentum are shifting into SNSE!! Could it be the next crazy runner of the day?? Only 500k float on SNSE - Bulls should keep it on watch!! Also watching: $VVPR $VRPX $LGVN $COSM news?
0 · Reply
Luvmepup
Luvmepup Aug. 8 at 10:36 PM
$COSM Opening in the 0.70's Monday ... at best!
0 · Reply
Luvmepup
Luvmepup Aug. 8 at 10:33 PM
$COSM Attack me personally if that makes you feel better about your horrible decision to invest in this scam ... we all know net earnings will be a disaster and probably good for another 20% dump.
0 · Reply
Kid_Shelleen
Kid_Shelleen Aug. 8 at 10:01 PM
$COSM and just like that, the board smells like wet dog. Welcome back.
0 · Reply
Luvmepup
Luvmepup Aug. 8 at 9:37 PM
$COSM Folks, net earnings will be a complete shit-show ... do not doubt me!
0 · Reply
Luvmepup
Luvmepup Aug. 8 at 9:35 PM
$COSM 🤣😆🤣
0 · Reply